Whitehawk Therapeutics WHWK
NASDAQ WHWK
$3.76 +0.03 (+0.80%)
At close: Sep 30, 2026 · 4:00 PM EDT

Whitehawk Therapeutics (WHWK) EV to EBITDA (2020 - 2021)

Updated

Whitehawk Therapeutics' EV to EBITDA came in at 2.02 for Q1 2021, down 47.3% from the prior quarter.

Analysis

Whitehawk Therapeutics (WHWK) EV to EBITDA (2020 - 2021) Analysis & Trends

Over the trailing twelve months to Mar 31, 2021, Whitehawk Therapeutics reported EV to EBITDA of -6.81.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Whitehawk Therapeutics 309.17 Mn 309.17 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 2.02
Dec 31, 2020 3.83
API Access

Whitehawk Therapeutics EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=WHWK&period=max&api_key=YOUR_API_KEY